ARCHIVES

NCAB Members Skeptical On NCI Reorganization; King Has “Alterative;” Terry T Head Centers

This article is from The Cancer Letter archive.

Vol. 04 No. 04 | January 27, 1978

Download PDF Visit The Full Archive

Related Articles

In Brief: Taxol Development Is NCI ‘Emergency Priority’, Dodd To Focus ACS Effort On Breast Screening

December 7, 1990

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

June 12, 1992

President Asks $989.3 Million fr NCI, But Mistake In Grant Allocations May Lead To Additional Money

February 4, 1983

Gemcitabine Improves DFS In Resected Pancreatic Cancer

June 24, 2005

DCT Advisors OK 4 Contract Concepts In Therapeutics

June 28, 1991

GAO Report: Taxol CRADA “Successful,” But Not Great Financial Deal.

June 27, 2003